Sign in
8-K

Current Report

Tempest Therapeutics, Inc. Filed Acc 0001104659-20-043387

Exit or restructuring costs · Other events

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading tm2015079-1_8k.htm…